姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Tan,Yong-He | Chairman | 9.94% | |
Fan Jiang,Su-Mei | Director | 7.37% | |
Zhan,Wen-Liang | Director | 0.00% | |
Huang,Jia-Zhe | Director | 0.00% | |
Xue,Tai-Jun | Independent Director | 0.00% | |
Chen,Ren-Jie | Independent Director | 0.00% | |
Lin,Wei-Fen | Independent Director | 0.00% |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 64,147 | 147,370 | 188,174 |
Operating cost | 43,914 | 103,976 | 134,061 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 20,233 | 43,394 | 54,113 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 20,233 | 43,394 | 54,113 |
Operating expenses | 36,383 | 69,285 | 73,038 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -16,150 | -25,891 | -18,925 |
Non-operating income and expenses | 210 | -533 | 1,670 |
Net profit (loss) before tax | -15,940 | -26,424 | -17,255 |
Income tax expense (benefits) | - | - | - |
Net profit (loss) of ongoing business for the current period | -15,940 | -26,424 | -17,255 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | -15,940 | -26,424 | -17,255 |
Other comprehensive profit (loss), net | - | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | -15,940 | -26,424 | -17,255 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | -1 | 0 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 110,136 | 125,303 | 154,100 |
Non-current asset | 12,304 | 11,390 | 12,491 |
Total asset | 122,440 | 136,693 | 166,591 |
Current liability | 54,247 | 49,394 | 52,689 |
Non-current liability | 7,072 | 10,238 | 10,417 |
Total liability | 61,319 | 59,632 | 63,106 |
share capital | 220,800 | 220,800 | 220,800 |
Equity - secruity token | - | - | - |
capital reserve | 77,758 | 77,758 | 77,758 |
retained earning | -237,437 | -221,497 | -195,073 |
Other equity | - | - | - |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 61,121 | 77,061 | 103,485 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 2 | 3 | 4 |